Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding | |
Chromosome | 1 | Map location | 1q22 | dbXrefs | Entrez:4582 MIM:158340 HGNC:HGNC:7508 Ensembl:ENSG00000185499 AllianceGenome:HGNC:7508 | |
Gene perturbation-related omics dataset | PerturbAtlas | |||||
Description | mucin 1, cell surface associated |
GTO ID | GTC1950 |
Trial ID | NCT03633773 |
Disease | Intrahepatic Cholangiocarcinoma |
Altered gene | MUC1 |
Therapeutic/Target gene | Target gene |
Therapy | CAR-T cell |
Treatment | MUC-1 CAR-T cells |
Phase | Phase1|Phase2 |
Recruitment status | Recruiting |
Title | Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma |
Year | 2018 |
Country | China |
Company sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
Other ID(s) | SAHZJU-Y2018-078 |
Cohort 1 | |||||||||
|